Publicacions en col·laboració amb investigadors/es de University Hospital of Lausanne (10)

2021

  1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

2020

  1. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697

  2. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

    Modern Pathology, Vol. 33, Núm. 5, pp. 792-801

2019

  1. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

    Lung Cancer, Vol. 131, pp. 95-103

2018

  1. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

    Journal of Thoracic Oncology, Vol. 13, Núm. 3, pp. 413-425

2017

  1. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project

    Lung Cancer, Vol. 111, pp. 143-149

2015

  1. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 290-295

2014

  1. Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project

    Journal of Clinical Oncology, Vol. 32, Núm. 25, pp. 2780-2787

2011

  1. A multilocus technique for risk evaluation of patients with neuroblastoma

    Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804

2009

  1. Influence of neuroblastoma stage on serum-based detection of MYCN amplification

    Pediatric Blood and Cancer, Vol. 53, Núm. 3, pp. 329-331